D-1179-2017 Class III Terminated

Recalled by Sandoz Inc — Princeton, NJ

FDA drug recall D-1179-2017 was initiated by Sandoz Inc on Sep 25, 2017 and is designated Class III. Reason for recall: Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels. The recall status is terminated (terminated Apr 8, 2019). Affected quantity: 13,435 shrink wrap packs.

Recall details

Product Type
Drugs
Report Date
Oct 4, 2017
Initiation Date
Sep 25, 2017
Termination Date
Apr 8, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,435 shrink wrap packs

Product description

Ampicillin for Injection, USP, 500 mg per vial, single vial (NDC 0781-3407-78) packaged in 10-count shrink wrap packs (NDC 0781-3407-95), Rx only, Manufactured in Austria by Sandoz GmbH or Sandoz Inc., Princeton, NJ 08540.

Reason for recall

Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot: GH8254, Exp 06/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1179-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1179-2017. Report a data issue: hello@regdatalab.com.